Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Titel:
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Auteur:
Traboulsee, Anthony Greenberg, Benjamin M Bennett, Jeffrey L Szczechowski, Lech Fox, Edward Shkrobot, Svitlana Yamamura, Takashi Terada, Yusuke Kawata, Yuichi Wright, Padraig Gianella-Borradori, Athos Garren, Hideki Weinshenker, Brian G